國立虎尾科技大學 |

Tumor Angiogenesis = A Key Target for Cancer Therapy /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Tumor Angiogenesis/ edited by Dieter Marmé.
其他題名:	A Key Target for Cancer Therapy /
其他作者:	Marmé, Dieter.
面頁冊數:	online resource. :
Contained By:	Springer Nature Living Reference
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-31215-6
ISBN:	9783319312156

Tumor Angiogenesis = A Key Target for Cancer Therapy /
Tumor AngiogenesisA Key Target for Cancer Therapy /[electronic resource] :edited by Dieter Marmé. - online resource.

Understanding of the molecular mechanisms of tumor development has increased considerably in recent years. As a consequence, the development of targeted therapies has proceeded rapidly, contributing to new drugs against cancer which are now under clinical investigation. Among these new therapies, anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer. This is due to the fact that tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.

ISBN: 9783319312156

Standard No.: 10.1007/978-3-319-31215-6doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Tumor Angiogenesis = A Key Target for Cancer Therapy /
LDR:02222nam a22003495i 4500 001 1022080
003 DE-He213
005 20200630222511.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783319312156 $9 978-3-319-31215-6
024 7 $a 10.1007/978-3-319-31215-6 $2 doi
035 $a 978-3-319-31215-6
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Tumor Angiogenesis $h [electronic resource] : $b A Key Target for Cancer Therapy / $c edited by Dieter Marmé.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
520 $a Understanding of the molecular mechanisms of tumor development has increased considerably in recent years. As a consequence, the development of targeted therapies has proceeded rapidly, contributing to new drugs against cancer which are now under clinical investigation. Among these new therapies, anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer. This is due to the fact that tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.
650 0 $a Oncology . $3 1253469
650 0 $a Cancer research. $3 1253664
650 0 $a Molecular biology. $3 583443
650 0 $a Pharmacology. $3 583819
650 1 4 $a Oncology. $3 593951
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Marmé, Dieter. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1309148
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature Living Reference
856 4 0 $u https://doi.org/10.1007/978-3-319-31215-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXRM
912 $a ZDB-2-SLR
950 $a Medicine (SpringerNature-11650)
950 $a Reference Module Medicine (SpringerNature-43750)